跳至主導覽
跳至搜尋
跳過主要內容
慈濟大學學研人才庫 首頁
帳號申請/資料更新
連結會在新分頁中打開
English
中文
在 慈濟大學學研人才庫 搜尋內容
首頁
專家檔案
研究單位
研究成果
貴重儀器
研究計畫
獎項
活動
新聞/媒體
查看斯高帕斯 (Scopus) 概要
彭 台珠
教授
護理學系(含碩士班、碩士在職專班)
https://orcid.org/0000-0002-5281-0246
電話
886-3-8572158#22257
電子郵件
ptc2008
gms.tcu.edu
tw
h-index
h10-index
h5-index
954
引文
19
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
153
引文
7
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
35
引文
4
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1989 …
2026
每年研究成果
概覽
指紋
網路
研究計畫
(5)
研究成果
(76)
新聞/媒體
(1)
類似的個人檔案
(6)
指紋
查看啟用 Tai-Chu Peng 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Nursing and Health Professions
Nurse
100%
Nursing
83%
Nursing Student
60%
Intensive Care Unit
51%
Blood Pressure
48%
Heart Rate Variability
44%
Acupuncture Point
42%
Education
38%
Biological Marker
36%
Quality of Life
34%
Long Term Care
34%
Esophageal Squamous Cell Carcinoma
34%
Radiotherapy
34%
Neoadjuvant Chemotherapy
34%
Palliative Therapy
34%
Fluid Resuscitation
34%
Hemorrhagic Shock
34%
Systematic Review
34%
Lung Cancer
34%
Compression Garment
34%
Sedative Agent
34%
Skin Temperature
27%
Staff Nurse
27%
Clinical Practice
26%
Health Care Personnel
20%
Cronbach Alpha Coefficient
20%
Nursing Staff
20%
Economic and Social Development
18%
Glucose Blood Level
17%
Public Health Nursing
17%
Nursing Competence
17%
Factor Analysis
17%
Music Therapy
17%
Kangaroo Care
17%
Wound Healing
17%
Acupressure
17%
Nurse Manager
17%
Electric Resistance
17%
Thermal Burn
17%
Heart Catheterization
17%
Bone Density
17%
Shoulder Pain
17%
Health Belief
17%
COVID-19
17%
Neck Pain
17%
Neoadjuvant Therapy
17%
Hemodialysis
17%
Hyperthermia
17%
Rooming-In
17%
Prevalence
17%
Medicine and Dentistry
Hemorrhagic Shock
34%
Liver Injury
34%
Fresh Water
34%
Sarcopenia
34%
Esophageal Cancer
34%
Tumor Necrosis Factor
26%
Adverse Event
23%
Supplementation
21%
Heart Rate Variability
21%
Treatment Outcome
19%
Lymphocyte
18%
Skin Surface
17%
Neoadjuvant Therapy
17%
Nutritional Biomarker
17%
Esophageal Squamous Cell Carcinoma
17%
Pain
17%
Anti-Inflammatory Drug
17%
Mouth Squamous Cell Carcinoma
17%
Esophagus Carcinoma
17%
Inflammation
17%
Neoadjuvant Chemotherapy
17%
Inflammatory Cytokine
17%
Muscle Injury
17%
Rosiglitazone
17%
Infection
17%
Epidermal Growth Factor Receptor
17%
Non Small Cell Lung Cancer
17%
Radiation Therapy
17%
Lung Adenocarcinoma
17%
Tyrosine-Kinase Inhibitor
17%
Interstitial Cystitis
17%
Cystalgia
17%
Toe
13%
Biological Marker
12%
Moxonidine
12%
Beck Anxiety Inventory
11%
Proportional Hazards Model
11%
Interleukin 6
10%
Cancer Staging
10%
Retrospective Study
10%
Autonomic Nerve
10%
Lactate Dehydrogenase
9%
Platelet
9%
Overall Survival
8%
Betel
8%
Thoracotomy
8%
Nutrition Assessment
8%
Cardiovascular System
8%
Chronic Obstructive Pulmonary Disease
8%
Aspartate Aminotransferase
8%
Pharmacology, Toxicology and Pharmaceutical Science
Hemorrhagic Shock
97%
Rat
75%
Tumor Necrosis Factor
45%
Clam
34%
Fresh Water
34%
Nitric Oxide
21%
Liver Injury
20%
Alanine Aminotransferase
20%
Aspartate Aminotransferase
20%
Lactate Dehydrogenase
19%
Spontaneously Hypertensive Rat
17%
Antioxidant Capacity
17%
Sarcopenia
17%
Lung Injury
17%
Ischemia
17%
Rosiglitazone
17%
Non Small Cell Lung Cancer
17%
Propofol
17%
Adverse Event
17%
Hypothermia
17%
Infection
12%
Interleukin 6
10%
Creatine Kinase
9%
Frailty
8%
Methylguanidine
8%
Organ Injury
7%
Survival Rate
6%
Interleukin 10
6%
Monocyte Chemotactic Protein 1
6%
Corbicula
5%
Nitric Acid Derivative
5%
Bleeding
5%
Arginine
5%
Haematoxylin
5%
Eosin
5%
